Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
British Journal of Haematology|August 27, 2024
Thrombopoietin improves the functions of bone marrow endothelial progenitor cells via METTL16/Akt signalling of haematological patients with chemotherapy-induced thrombocytopeniaHui Chen, Yingying Jiao, Chao Lin, et al.
Oncotarget|September 19, 2015
The hypomethylating agent decitabine prior to chemotherapy improves the therapy efficacy in refractory/relapsed acute myeloid leukemia patientsXuejie Jiang, Zhixiang Wang, Bingjie Ding, et al.
Immunology Letters|November 25, 2023
Platelet dropping, bleeding and new treatment requirements in ITP patients after inactivated COVID-19 vaccinationXiao-Yong Zhan, Hui Chen, Huimin Kong, et al.
Cancer|March 7, 2018
Effect of sorafenib on the outcomes of patients with FLT3-ITD acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantationLi Xuan, Yu Wang, Fen Huang, et al.
Journal of Hematology & Oncology|March 14, 2020
Haploidentical versus HLA-matched sibling transplantation for refractory acute leukemia undergoing sequential intensified conditioning followed by DLI: an analysis from two prospective dataSijian Yu, Fen Huang, Zhiping Fan, et al.
Leukemia|November 18, 2020
A new pre-emptive TKIs strategy for preventing relapse based on BCR/ABL monitoring for Ph+ALL undergoing allo-HCT: a prospective clinical cohort studyHui Liu, Li Xuan, Ren Lin, et al.
Molecular Cancer Therapeutics|September 10, 2009
Adenovirus-mediated down-regulation of X-linked inhibitor of apoptosis protein inhibits colon cancerYun Dai, Liang Qiao, Kwok Wah Chan, et al.
The Lancet. Haematology|January 26, 2023
The effect of granulocyte-colony stimulating factor, decitabine, and busulfan-cyclophosphamide versus busulfan-cyclophosphamide conditioning on relapse in patients with myelodysplastic syndrome or secondary acute myeloid leukaemia evolving from myelodysplastic syndrome undergoing allogeneic haematopoietic stem-cell transplantation: an open-label, multicentre, randomised, phase 3 trialLi Xuan, Min Dai, Erlie Jiang, et al.
BMJ Open|December 30, 2023
Changing epidemiology, microbiology and mortality of bloodstream infections in patients with haematological malignancies before and during SARS-CoV-2 pandemic: a retrospective cohort studyLinjing Cai, Huan Chen, Yongqiang Wei, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 12, 2024
Homoharringtonine Added to Venetoclax and Azacitidine Improves Outcome and Mitigates Genetic Impact in Relapsed/Refractory AML: A Multicenter Cohort StudyGuopan Yu, Yu Zhang, Sijian Yu, et al.
Pageof 3